Erik Domingues, MD
Dermatology · Fall River, MANPI 1962713370
Payments from drug & device makers
Across 1,465 payments — averaging $502.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$223K
- Pfizer$168K
- Incyte Corporation$158K
- E.r. Squibb & Sons, L.L.C.$65K
- Galderma Laboratories, L.p.$56K
- UCB, Inc.$44K
- plus $21K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 306 | $223,339 |
| Pfizer | 196 | $167,886 |
| Incyte Corporation | 242 | $158,301 |
| E.r. Squibb & Sons, L.L.C. | 154 | $65,374 |
| Galderma Laboratories, L.p. | 82 | $56,298 |
| UCB, Inc. | 77 | $44,083 |
| AbbVie(2 entities) | 195 | $12,478 |
| Johnson & Johnson | 86 | $3,904 |
| LEO Pharma Inc. | 51 | $996 |
| Kowa Pharmaceuticals America, Inc. | 1 | $650 |
| Sun Pharmaceutical Industries Inc. | 5 | $408 |
| Novartis | 11 | $393 |
| Regeneron Healthcare Solutions, Inc. | 10 | $308 |
| Sanofi | 13 | $250 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $227 |
| Lilly USA, LLC | 11 | $226 |
| Eli Lilly | 1 | $175 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Amgen | 4 | $89 |
| Revance Therapeutics, Inc. | 2 | $62 |
| Boehringer Ingelheim | 2 | $61 |
| Stemline Therapeutics Inc. | 1 | $57 |
| Blueprint Medicines Corporation | 1 | $48 |
| LNHC, Inc | 2 | $40 |
| Medline Industries LP | 1 | $29 |
| Bristol Myers Squibb | 1 | $21 |
| Merz North America, Inc. | 1 | $16 |
| Organon | 1 | $6 |
How this compares
$735,850 in reported general payments places this provider in the 95th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Fall River
- David WalkerFall River$114K
- John HarrisWorcester$17.1M
- Mark AmsterBrighton$5M
- David GreensteinBeverly$4M
- Alexandra KimballBoston$3.7M
- Robert NossaMarstons Mills$2.6M
- Gideon SmithBoston$2.6M
- Victoria KuohungQuincy$1.8M
- Ethan LernerCharlestown$1.7M
- Jeffrey DoverChestnut Hill$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.